Abstract:Lijuan Wang, 1, &ast Huoliang Liu, 2, &ast Yi Wang, 1 XiaoFan Hong, 1 Xiaoyan Huang, 1, 3, 4 Miaoru Han, 1 Dan Wang, 1 Wenjun Shan, 1 Ping Li, 1, 3 Haowen Gu, 1 Bo Liu, 3, 5 Kun Bao 1, 3, 4, 6 1 Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, People's Republic of China; 2 The Affiliated TCM Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China; 3 State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, People's Republic of China; 4 Guangdong-Hong Kong-Macau Joint Laboratory on Chinese Medicine and Immune Disease Research, Guangzhou, People's Republic of China; 5 Guangzhou Key Laboratory of Chirality Research on Active Components of Traditional Chinese Medicine, Guangzhou, People's Republic of China; 6 Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Disease, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine), Guangzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Bo Liu; Kun Bao, Email ; Background: Nephrotic syndrome (NS) and its numerous complications remain the leading causes of morbidity and mortality globally. Sanqi Qushi granule (SQG) is clinically effective in NS. However, its potential mechanisms have yet to be elucidated. Methods: A network pharmacology approach was employed in this study. Based on oral bioavailability and drug-likeness, potential active ingredients were picked out. After acquiring overlapping targets for drug genes and disease-related genes, a component-target-disease network and protein–protein interaction analysis (PPI) were constructed using Cytoscape, followed by GO and KEGG enrichment analyses. Adriamycin was injected into adult male Sprague-Dawley (SD) rats via the tail vein to establish NS model. Kidney histology, 24-hr urinary protein level, creatinine (Cr), blood urea nitrogen (BUN), triglyceride (TG), total cholesterol (TC), and low-density lipoprotein (LDL-C) level were assessed. Western blotting, immunohistochemistry, and TUNEL staining were applied. Results: In total, 144 latent targets in SQG acting on NS were screened by a network pharmacology study, containing AKT, Bax, and Bcl-2. KEGG enrichment analysis suggested that PI3K/AKT pathway was enriched primarily. In vivo validation results revealed that SQG intervention ameliorated urine protein level and podocyte lesions in the NS model. Moreover, SQG therapy significantly inhibited renal cells apoptosis and decreased the ratio of Bax/Bcl-2 protein expression. Moreover, we found that Caspase-3 regulated the PI3K/AKT pathway in NS rats, which mediated the anti-apoptosis effect. Conclusion: By combining network pharmacology with experimental verification in vivo, this work confirmed the treatment efficacy of SQG for NS. SQG protected podocyte from injury and inhibited kidney apoptosis in NS rats via the PI3K/AKT pathway at least partially. Keywords: Sanqi Qushi granule, nephrotic syndrome, podocyte injury, kidney apoptosis, network pharmacology, PI3K/AKT pathway Nephrotic syndrome (NS) manifests a range of clinical conditions of massive proteinuria, edema, hypoproteinemia, and hyperlipidemia. 1 Patients with NS are generally more susceptible to hypertension, thrombotic events, and serious infections. 2 Prednisone is often the first-line therapy for NS. 3 Management of NS is very challenging because 10%–20%of patients develop steroid-resistant nephrotic syndrome (SRNS). 3 Moreover, an overwhelming majority of individuals with SRNS progress to Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD) within a few years. 2,4 Currently, there is no specific treatment to curb disease progression into ESRD. 2 Hence, it is urgent to develop effective drugs for NS. Sanqi Qushi Granule (SQG) is derived from Sanqi oral solution, which is a hospital preparation for clinical use in Guangdong Provincial Hospital of Chinese Medicine. 5 Our group confirmed that Sanqi oral solution could exert protective effects in podocyte and mitigate proteinuria. 6,7 Further, the Sanqi Qushi Granule was tolerable, and clinically effective in lowering proteinuria for individuals with NS. However, the underly -Abstract Truncated-

Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism

Clinical Characteristics and Prognostic Factors of Nephrotic Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation

Mutations in Multiple Components of the Nuclear Pore Complex Cause Nephrotic Syndrome

Podocyte-specific Nup160 knockout mice develop nephrotic syndrome and glomerulosclerosis

A Novel Mutation of NPHS2 Identified in a Chinese Family with Steroid-Resistant Nephrotic Syndrome

GAPVD1 and ANKFY1 Mutations Implicate RAB5 Regulation in Nephrotic Syndrome.

NPHS1 and NPHS2 Gene Mutations in Chinese Children With Sporadic Nephrotic Syndrome

Mutations in the NUP93, NUP107 and NUP160 genes cause steroid-resistant nephrotic syndrome in Chinese children

The Clinical and Genetic Features in Chinese Children With Steroid-Resistant or Early-Onset Nephrotic Syndrome: A Multicenter Cohort Study

Nucleoporin-associated steroid-resistant nephrotic syndrome

A novel mutation of NPHS2 identified in a Chinese family

Genetic Variations of the NR3C1 Gene in Children with Sporadic Nephrotic Syndrome.

Integrated single-cell RNA-seq analysis revealed podocyte injury through activation of the BMP7/AMPK/mTOR mediated autophagy pathway

Case Report: The Monogenic Familial Steroid-Resistant Nephrotic Syndrome Caused by a Novel Missense Mutation of NPHS2 Gene A593C in a Chinese Family

Mutations in Six Nephrosis Genes Delineate a Pathogenic Pathway Amenable to Treatment.

NPHS Mutations in Pediatric Patients with Congenital and Steroid-Resistant Nephrotic Syndrome

Analysis of 24 Genes Reveals a Monogenic Cause in 11.1% of Cases with Steroid-Resistant Nephrotic Syndrome at a Single Center

[Analysis on Association of Glucocorticoid Receptor Gene Polymorphism with Steroid-Resistance in Idiopathic Nephrotic Syndrome of Children].

Spectrum of mutations in Chinese children with steroid-resistant nephrotic syndrome

Sanqi Qushi Granule Alleviates Proteinuria and Podocyte Damage in NS Rat: A Network Pharmacology Study and in vivo Experimental Validation

A genomic association study revealing subphenotypes of childhood steroid-sensitive nephrotic syndrome in a larger genomic sequencing cohort